| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |